IDEAYA Biosciences股价上涨2.3%,因其药物组合在罕见眼癌试验中显示生存获益。
IDEAYA Biosciences股价上涨2.3%,因其药物组合在罕见眼癌试验中显示生存获益。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.